BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 315847)

  • 1. PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.
    Robert KH
    Clin Exp Immunol; 1979 Sep; 37(3):517-22. PubMed ID: 315847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sera from chronic lymphocytic leukemia patients on normal mitogen-stimulated lymphocytes. A possible correlation with the patients' T and B lymphocytes.
    Komlos L; Halbrecht I; Shachor J; Djaldetti M
    Exp Hematol; 1978 Aug; 6(7):595-600. PubMed ID: 308462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of T lymphocytes by protein A from Staphylococcus aureus in B-derived chronic lymphocytic leukaemia.
    Guglielmi P; Preud'Homme JL
    Clin Exp Immunol; 1980 Jul; 41(1):136-40. PubMed ID: 6969148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocytes bearing Fc-receptors for IgG in B-cell chronic lymphocytic leukaemia.
    Matolcsy A; Magyarlaki T; Baliko Z; Tornoczky J
    Haematologia (Budap); 1985; 18(3):185-91. PubMed ID: 2941348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of B leukemic lymphocytes of patients with chronic lymphocytic leukemia to PWM and PHA.
    Isaković K; Lenert G
    Blood Cells; 1987; 12(2):355-64. PubMed ID: 3497681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte immunological patterns in leukaemia: a review.
    Atsaldi G; Astaldi GC; Topuz U; Guarina L
    Haematologia (Budap); 1975; 9(1-2):21-33. PubMed ID: 780227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of lymphocyte subpopulations in patients with chronic lymphocytic leukemia.
    Rühl H; Scholle H; Bochert G; Vogt W
    Z Immunitatsforsch Immunobiol; 1978; 154(1):75-87. PubMed ID: 146347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of chronic lymphatic leukaemia cells by pokeweed mitogen after treatment with neuraminidase-galactose oxidase.
    Zafar MN; Pittman S; Cherchi M; Catovsky D
    Clin Exp Immunol; 1981 Apr; 44(1):124-8. PubMed ID: 6973427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between the capacity to be stimulated of lymphocyte subpopulations and the RAI staging in patients with chronic lymphocytic leukemia].
    Heilmann E; Venne U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):365-74. PubMed ID: 89987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of leukaemic and residual normal cells in the proliferative response of chronic lymphocytic leukaemic lymphocytes to mitogens.
    Johnstone AP; Millard RE; Hudson L
    Clin Exp Immunol; 1982 Mar; 47(3):689-96. PubMed ID: 6979444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different maturation capabilities of chronic lymphocytic leukaemia lymphocytes in vitro.
    Rozynkowa D; Rupniewska ZM; Antosz H
    Cytobios; 1986; 48(192):31-7. PubMed ID: 3491741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia.
    Robèrt KH; Möller E; Gahrton G; Eriksson H; Nilsson B
    Clin Exp Immunol; 1978 Aug; 33(2):302-8. PubMed ID: 309812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-lymphocyte subpopulation in the blood of patients with chronic lymphocytic leukemia].
    Holowiecki J; Stella B; Krawczyk M; Rudzka E
    Acta Haematol Pol; 1976; 7(2):111-6. PubMed ID: 1084671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphatic leukemia lymphocytes.
    Faguet GB
    J Clin Invest; 1979 Jan; 63(1):67-74. PubMed ID: 153914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [T- and B-lymphocytes in lymphoproliferative diseases].
    Tsveibakh AS; Gol'dman EI
    Vopr Onkol; 1978; 24(1):11-6. PubMed ID: 305684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and biological functions of human IgD. XII. Anti-IgD enhancement of PHA responsiveness in patients with chronic lymphocytic leukaemia.
    Kermani-Arab V; Leslie GA; Burger DR
    Clin Exp Immunol; 1977 Dec; 30(3):450-6. PubMed ID: 414869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL).
    Ukaejiofo EO; Sagoe AS; Osunkoya BO
    Afr J Med Med Sci; 1983; 12(3-4):197-202. PubMed ID: 6326554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble factor(s) released by Concanavalin A activated lymph node lymphocytes induce proliferation and maturation of chronic lymphocytic leukaemia (CLL) B lymphocytes.
    Matera L; Massaia M; Pegoraro L
    J Clin Lab Immunol; 1984 Feb; 13(2):85-8. PubMed ID: 6427468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
    Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
    J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin.
    Maino VC; Kurnick JT; Kubo RT; Grey HM
    J Immunol; 1977 Mar; 118(3):742-8. PubMed ID: 403235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.